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Abstract
Background: µ-calpain and m-calpain are ubiquitously expressed proteases implicated in cellular
migration, cell cycle progression, degenerative processes and cell death. These heterodimeric
enzymes are composed of distinct catalytic subunits, encoded by Capn1 (µ-calpain) or Capn2 (m-
calpain), and a common regulatory subunit encoded by Capn4. Disruption of the mouse Capn4 gene
abolished both µ-calpain and m-calpain activity, and resulted in embryonic lethality, thereby
suggesting essential roles for one or both of these enzymes during mammalian embryogenesis.
Disruption of the Capn1 gene produced viable, fertile mice implying that either m-calpain could
compensate for the loss of µ-calpain, or that the loss of m-calpain was responsible for death of
Capn4-/- mice.
Results: To distinguish between the alternatives described above, we deleted an essential coding
region in the mouse Capn2 gene in embryonic stems cells and transmitted this mutant allele through
the mouse germline. Breeding of heterozygous animals failed to produce homozygous mutant live
offspring or implanted embryos. A nested PCR genotyping protocol was established, and
homozygous preimplantation mutant embryos were detected at the morula but not at the
blastocyts stage.
Conclusion:  We conclude that homozygous disruption of the Capn2  gene results in pre-
implantation embryonic lethality between the morula and blastocyst stage. This establishes that µ-
calpain and m-calpain have distinct functions, and that m-calpain is vital for development of the
preimplantation murine embryo.
Background
The two ubiquitous Ca2+-dependent, cysteine proteases
known as µ-calpain (calpain-1) and m-calpain (capain-2),
are the founding members of a gene family comprising 13
genes in mammals [1-3]. Both are heterodimeric enzymes
consisting of distinct 80 kDa catalytic subunits, encoded
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by the Capn1 (µ-80 k) and Capn2 (m-80 k) genes, respec-
tively, that associate with a common 28 kDa regulatory
subunit encoded by the Capn4 gene. The µ-80 k and m-80
k subunits share 62% amino acid sequence identity, and
are very similar in terms of structure, protein chemistry,
and in vitro substrate specificity. Despite these similarities,
the differential expression patterns of µ- and m-calpain in
mammalian tissues suggest they have some isoform spe-
cific and distinct functions. The µ and m designations
derive from the levels of Ca2+ required in vitro for optimal
activation; 10–50 µM Ca2+ for  µ-calpain and 0.3–0.35
mM Ca2+ for m-calpain. It is generally assumed that µ- and
m-calpain maintain their differential sensitivities to cal-
cium in vivo, although this has not yet been strictly dem-
onstrated. Furthermore, since the cytoplasmic free Ca2+
concentration is typically less than 1 µM, it is also
assumed that other in vivo factors must contribute to reg-
ulation of these enzymes [3].
Without apriori knowledge of the factors regulating cal-
pain activity or their relevant substrates, elucidation of
biological functions for calpains presents a challenge.
Research on calpains has linked them with a wide variety
of functions including muscle growth, development,
degeneration (3), neuronal growth and neurodegenera-
tion [4], cell cycle progression [5,6], signal cascades trig-
gered by integrins and growth factors [7], membrane
protrusion [8], remodeling of the cytoskeleton and cell
migration [9-15], and regulation of cell death via both
necrosis and apoptosis [16-22]. To date, the literature sug-
gests a complex interplay between caspases and calpains
[23,24] and impact of calpain on cell death pathway com-
ponents [25]. The lack of highly specific cell-permeable
inhibitors of calpains contributes to the challenge of
investigating and defining calpain functions in these proc-
esses. Although over-expression of calpastatin, the endog-
enous protein inhibitor of µ- and m-calpain provides an
important approach for these efforts, it will not distin-
guish isoform specific functions [24,26,27]. Some work
has suggested isoform specific roles, such as a role for m-
calpain in epidermal growth factor (EGF)-induced cell
motility [28,29] and a role for µ-calpain in interferon-
inducible protein 9-induced migration of keratinocytes
[28]. A cell permeable calpain inhibitor (which likely
inhibits other thiol-proteases as well) has been used to
select cells lacking µ-calpain which display reduced prolif-
eration rates [30]. Interestingly, m-calpain expression per-
sisted in these cells, suggesting a possible requirement of
m-calpain for cell survival [30].
Targeted gene deletion in mice provides a powerful
approach to determining the physiological roles of µ- and
m-calpain and the opportunity to approach their isoform
specific functions. Initial studies targeted Capn4 based on
the prediction that loss of this calpain subunit would
abolish activity of both µ- and m-calpain. Capn4-/- murine
embryos died between days 10 and 11 of gestation, and
there was no detectable µ- or m-calpain activity in these or
younger embryos [31]. Capn4-/- murine embryonic fibrob-
lasts (MEFs) could be cultured from these embryos,
although they also lacked calpain activity as assessed by
casein zymography or by the formation of characteristic
spectrin breakdown products, and they displayed migra-
tion defects consistent with a role for calpain in release of
focal adhesions [9]. An independently derived Capn4
knockout, involving a more extensive deletion of the
gene, resulted in an earlier embryonic lethality, appar-
Targeting strategy for disruption of the murine Capn2 gene Figure 1
Targeting strategy for disruption of the murine 
Capn2 gene. The murine Capn2 gene, encoding the m-80 k 
subunit, was disrupted in ES cells by homologous recombina-
tion. The structures of the wild-type allele (top), the target-
ing vector (middle), and the mutant allele (bottom) are 
depicted. In the mutant allele, a PGK-Neo cassette replaces a 
0.8-kb genomic fragment containing exon 7 (grey rectangle) 
which encodes the active site asparagine residue (Asn286) In 
the targeting vector, the PGK-Neo cassette is flanked by 2.7-
kb of Capn2 homologous sequence in the upstream (short) 
arm and 7.9-kb of homology in the downstream (long) arm. 
A probe located immediately outside of the short arm 
detects a 3.5-kb BamHI fragment from the wild-type allele 
and a 5.3-kb BamHI fragment from the mutant allele. Exons 
are depicted as open vertical rectangles except for exon 7 
which is represented by a solid vertical rectangle. The probe 
used in most Southern blot analyses is shown as a solid, hor-
izontal rectangle, while triangles mark the positions of PCR 
primers also used for genotyping purposes.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
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ently at a pre-implantation stage [32]. The different times
of embryonic lethality suggested that the first reported
Capn4-/- mice [31] were targeted with a hypomorphic
mutation, which retained some small level of calpain
activity, allowing for their survival to mid-gestation, while
the second reported Capn4-/- mice [32] represented a true
null mutation. Disruption of Capn1, encoding the µ-cal-
pain catalytic subunit, was subsequently reported to result
in fertile, viable mice with some mild defects in the µ-cal-
pain rich platelets relating to their aggregation and clot
retraction [33]. The fact that Capn4 null mice die during
embryogenesis indicates that at least one of the ubiqui-
tous calpains is essential for development to term. The
viability of Capn1-deficient mice does not however distin-
guish between two possibilities: either that m-calpain is
specifically required during embryogenesis, or that either
form of calpain alone is sufficient and can compensate for
the absence of the other. To resolve this question, we have
now knocked out the Capn2 gene encoding the m-80 k
subunit in mice. We report here that Capn2 null embryos
died prior to the implantation stage, indicating that m-cal-
pain is indispensable for early embryogenesis. This role
cannot be fulfilled by µ-calpain, which is expressed in
embryonic stem (ES) cells [31] and is assumed to be
present at this stage of gestation. This demonstrates une-
quivocally that m-calpain and µ-calpain have distinct
physiological roles during early embryogenesis.
Results
Isolation and characterization of Capn2 targeted ES cell 
clones
Two independent Capn2+/- ES cell lines, designated ES27
and ES36, were isolated from a screen of 305 drug-resist-
ant clones. Correct targeting of the Capn2 locus was estab-
lished both by Southern blot hybridization and PCR
analysis. A probe located outside the short (upstream)
arm of homology hybridized to a 3.5-kb BamHI fragment
of the wild-type allele and 5.3-kb BamHI fragment of the
mutant allele as predicted from genomic maps (Figure
2A). The same probe also detected the expected 7.2-kb
wild-type and 6.4-kb mutant BglII fragments, 4.9-kb wild-
type and 5.7-kb mutant NcoI fragments, as well as 7.2-kb
wild-type and 4.9-kb mutant BglII/AgeI fragments (not
shown). A probe derived from the PGK-Neo cassette rec-
ognized only the 5.3-kb BamHI fragment in Capn2+/- ES
cells, suggesting that the targeting vector had integrated
solely at the Capn2 locus (not shown). A PCR screening
method was also established that generated a wild-type
product of 2,749 bp and a 2,711 bp product from the
mutant allele. The 2,711 bp product was only evident in
the two targeted cell lines (Figure 2B).
Generation of chimeric mice and germline transmission of 
the mutant Capn2 allele
Eight chimeric male mice were produced in morula aggre-
gation experiments using the Capn2+/- ES27 cell line. Two
of these males transmitted the Capn2+/- ES27 genotype
through the germline into the F1  generation. Hetero-
zygous Capn2+/- animals appeared normal, with no obvi-
ous defects in gross anatomy, reproduction, or life span.
Out of 199 weanlings from heterozygous intercrosses, no
Capn2-/- progeny were detected (Table 2). We did not
observe high rates of perinatal death, and no Capn2-/- still-
borns were observed. This suggested that Capn2-/- animals
perished at some stage during embryonic development. In
an attempt to determine if embryonic death occurred at a
Characterization of targeted ES cell lines Figure 2
Characterization of targeted ES cell lines. (A) Targeted 
disruption of the Capn2 locus was detected initially by South-
ern blotting. Membranes were blotted with BamHI-digested 
genomic DNA extracted from ES cells and hybridized with a 
DIG-labeled 823 bp BamHI/HindIII fragment located immedi-
ately upstream of the short arm of the targeting vector (Fig-
ure 1). A 3.5-kb BamHI fragment corresponding to the wild-
type allele was present in all cells, whereas a 5.3-kb fragment 
from the mutant allele was detected in two targeted cell 
lines, designated ES27 and ES36. (B) PCR genotyping was car-
ried out with two separate reactions designed to amplify 
either a 2,748 bp segment from the wild-type allele or a 
2,711 bp segment from the mutant allele. Both reactions 
used a common sense primer located in intron 4, outside the 
short arm of the targeting vector, and distinct allele-specific 
antisense primers. The reaction to detect the wild-type allele 
used an antisense primer located in exon 7 while the amplifi-
cation of the mutant sequence was done with an antisense 
primer in the PGK-Neo cassette. The results confirm the 
presence of the wild-type allele in all cells, whereas the 
mutant allele signal was observed only in the two targeted 
clones. (M) denotes the molecular weight marker.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
Page 4 of 11
(page number not for citation purposes)
post-implantation stage, embryos were harvested for gen-
otyping at different times between E10.5 and E18.5. No
Capn2-/- embryos were observed and no signs of embryo
resorption were detected (Table 2). This indicated that the
Capn2-/- embryos might be dying prior to implantation.
Embryos were then flushed from the oviducts of pregnant
females at E2.5 or E3.5, and genotyped by means of a
nested PCR strategy (Figure 4). Two of 90 successfully gen-
otyped pre-implantation embryos were Capn2-/-, (Table 2;
Figure 5). Both of these Capn2-/- embryos were isolated at
the 8-cell stage and did not display any obvious morpho-
logical defects. None of the 46 successfully genotyped
blastocyst-staged embryos were Capn2-/-. The scarcity of
Capn2-deficient embryos surviving to the 8-cell stage sug-
gested that the loss of m-calpain activity must fatally com-
promise the viability of early embryos. Furthermore, it is
possible that persistence of some maternally derived
mRNA transcript or protein might have allowed a small
number of Capn2-/- embryos to survive to the morula-
stage.
The genotyping results for weanlings, post-implantation,
and pre-implantation embryos are shown in Table 2.
Curiously, the ratio of Capn2+/+ to Capn2+/-animals
from inbred heterozygous intercrosses was substantially
less than the predicted 1:2 Mendelian ratio. In a group of
199 animals derived from heterozygote breeding (33 lit-
ters), 23 Capn2+/+ (11.6%) and 176 (88.4%) Capn2+/-
animals were observed. The ratio of Capn2+/+ to Capn2+/
- animals among males (14% to 82%) or females (13% to
Table 1: Oligonucleotide primers used to genotype the Capn2 locus
Allele Primer Location Oligonucleotide Sequence
Single-Step
Both Sense Intron 4 5'-GGGCCCCCATTGCCTCTTAGC-3'
Wild-type Antisense Exon 7 5'- GGATTCCTGATGCGGATCAATTTCTGC-3'
Mutant Antisense PGK-Neo 5'-CCTCGAAGTCGAGGTCGATCC-3'
Nested PCR
Wild-Type (Diagnostic) Sense #1 Intron 6 5'-CAACATCATAAGCAACGGAGAACGC-3'
Sense #2 Intron 6 5'-GCCTGTGACAGAAGTACCACCAG-3'
Antisense #1 Intron 7 5'-CTCCTCGGCCCTCCCTGTAG-3'
Antisense #2 Exon 7 5'-GGATTCCTGATGCGGATCAATTTCTGC-3'
Mutant (Diagnostic) Sense #1 Intron 6 5'-CAACATCATAAGCAACGGAGAACGC-3'
Sense #2 Intron 6 5'-GCCTGTGACAGAAGTACCACCAG-3'
Antisense #1 PGK-Neo 5'-CCTACCCGGTAGAATTGACCTGC-3'
Antisense #2 PGK-Neo 5'-GACCTGCAGGGGCCCTC-3'
Both (Internal Control) Sense #1 Intron 4 5-GGGATGAAGGCTCCCTGTTGC-3'
Sense #2 Exon 5 5'-GGGGGTGCCACCACGGAA -3'
Antisense #1 Intron 5 5'-CCCCTAGAGGACTATTGCCTGG-3'
Antisense #2 Intron 5 5'-GATGCACCCATGCCTTAAGGAGC-3'
Table 2: Genotype distribution of offspring derived from Capn2 transgenic mice.
Cross (N) Age Genotype
+/+ +/- -/- ND*
(+/-) × (+/-) 199 3 weeks 23 176 0 0
(+/+) × (+/-) 122 3 weeks 50 72 0 0
(+/-) × (+/+) 103 3 weeks 28 75 0 0
(+/-) × (+/-) 9E 1 8 . 5 0702
(+/-) × (+/-) 5E 1 7 . 5 0500
(+/-) × (+/-) 9E 1 4 . 5 2700
(+/-) × (+/-) 1 0 E 1 1 . 5 3700
(+/-) × (+/-) 7E 1 0 . 5 2500
(+/-) × (+/-) 46 E3.5 7 39 0 0
(+/-) × (+/-) 48 E2.5 8 34 2 4
* ND, not determinedBMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
Page 5 of 11
(page number not for citation purposes)
90%) was essentially the same is it was for the combined
population, and there were an average of six pups per lit-
ter, which is normal for this background strain. A larger
than expected proportion Capn2+/- animals was also evi-
dent in both post-implantation and pre-implantation
embryos (Table 2). Interestingly, a similar over-represen-
tation of heterozygous animals was also reported in one
of the Capn4 transgenic lines, though the genotype skew-
ing was not as extreme [32]. Crosses between Capn2+/+
and Capn2+/- animals also resulted in a greater than
expected proportion of Capn2+/- animals (Table 2). An
even higher degree of Capn2+/- over-representation was
seen when the mutant allele came the mother (73%) com-
pared to when it came from the father (59%). In these
crosses the ratios of Capn2+/+ to Capn2+/- animals
among males or females compared well with the ratio in
the combined populations; 77% of males and 69% of
females were Capn2+/- when the mutant allele came from
the mother, and 62% of males and 55% of females were
Capn2+/- when the mutant allele came from the father.
Attempted generation of Capn2-/- ES cells
Capn2+/- ES cells were subjected to clonal selection in the
presence of 2 mg/mL G418 in attempts to generate
homozygous mutant cells by gene conversion. This proce-
dure has been extensively applied to targeted ES cells and
was readily achieved in the case of Capn4+/- ES cells [31].
In this case, however, no Capn2-/- ES cells were isolated in
screens of 126 drug-resistant clones. The inability to iso-
late Capn2-/- ES cells, in concert with the absence of Capn2-
/- embryos beyond the 8-cell stage, suggested that m-cal-
pain activity might be essential for cell viability or the
establishment of viable ES cell clones.
Discussion
Although calpain activity was first identified four decades
ago, a clear understanding of the substrates and functions
of the enzymes has remained elusive. In large part, this
has been due to the lack of inhibitors capable of specifi-
cally down-regulating the calpains without affecting other
proteases. In the past decade, the story has been further
complicated by the discovery of a number of previously
unknown isoforms which may be differently regulated
and have different substrate specificity. Gene targeting in
mice has provided a powerful approach to examine the
physiologic roles of individual calpain isoforms. This was
first used to disrupt the Capn4 gene, encoding the small
regulatory subunit common to both µ- and m-calpain.
Two independent laboratories observed embryonic
lethality in Capn4 knockout mice, albeit at different stages
of development [31,32]. These observations supported
the hypothesis that the small subunit is required for both
µ- and m-calpain, and furthermore suggested four possi-
bilities regarding their requirement for embryonic devel-
opment: 1) both isoforms were required; 2) µ-calpain was
required; 3) m-calpain was required, or 4) µ- and m-cal-
pain are redundant, and one or the other isoform was
required. These options were narrowed down by the sub-
sequent observation that Capn1-/- mice, which lack the µ-
calpain catalytic subunit, were healthy and fertile,
although platelet aggregation and clot retraction defects
were observed [33]. At that point, we were left with the
last two possibilities that either m-calpain was specifically
required during embryogenesis, or that either isoform
alone was sufficient for sustaining embryonic viability.
We report here that Capn2-/- mice, which lack the m-cal-
pain catalytic subunit, die at the preimplantation stage of
development. This observation allows us to now conclude
that m-calpain is specifically required during embryogen-
esis. Since homozygous disruption of the Capn4 gene was
also expected to abolish m-calpain activity, this result is in
agreement with the phenotype presented by one of the
two  Capn4  targeted lines in which preimplantation
lethality of null embryos was also observed [32]. The sur-
vival of Capn4-/- embryos from the original targeted line
reported by Arthur and colleagues to mid-gestation is
more difficult to reconcile [31]. In retrospect, it seems
likely that the latter line represents a hypomorphic state,
rather than a true null. The Capn4  targeting strategy
employed by Arthur and colleagues involved disrupting
the C-terminus of the calpain small subunit by insertion
of the PGK-Neo cassette into the middle of exon 9, which
caused truncation of the protein [31]. This strategy was
based upon previous structure/function studies showing
that excision of the C-terminal 25 amino acid residues of
the small subunit abolished calpain activity when co-
expressed with the m-calpain large subunit in E. coli [34].
In contrast, the Capn4  targeting strategy employed by
Genotyping of weanlings from heterozygote intercrosses Figure 3
Genotyping of weanlings from heterozygote inter-
crosses. A representative example of the Southern blot gen-
otyping of progeny from a Capn2+/- intercross is shown. 
Genomic DNA was extracted from mouse tail biopsies taken 
from three-week old weanlings and genotyped by Southern 
blotting as described in Figure 1. A 3.5-kb BamHI fragment 
from the wild-type allele was detected in all animals while a 
5.3-kb BamHI fragment from the mutant allele was observed 
in a subset of progeny. No Capn2-/- offspring were detected 
among weanlings or post-implantation embryos, nor were 
embryo resorption sites observed. These results indicate 
that Capn2-/- embryos perished at a pre-implantation stage.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
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Zimmerman and colleagues involved a much more exten-
sive deletion of exons 4 through 8 [32]. It now seems
probable that the difference in the time of lethality of
these two targeted Capn4 lines can be explained by differ-
ent extents of disruption. The Zimmerman allele probably
represents a true null genotype while the Arthur allele is
likely a hypomorphic mutation. Alternate targeting strate-
gies have been shown to yield different phenotypes in
gene disruption studies. For example, three different tar-
geting strategies were independently used to disrupt the
mixed lineage leukemia (Mll) gene. In all three studies,
homozygous null embryos perished during embryogene-
sis, but at different stages (E0.5, E10.5, E14.5) [35]. The
variation in phenotype was attributed to the differences in
degree of function of the truncated proteins produced
from the mutant alleles. A similar effect might be at work
in the two Capn4 transgenic lines. Efforts were made to
detect transcripts or calpain activities derived from the
Arthur  Capn4  allele. This allele gave rise to multiple
mRNA species, detectable by RT-PCR, reading through
from the first half of exon 9 to at least two different cryptic
splice sites in the PGK promoter sequence [31]. These
transcripts could give rise to defective calpain small subu-
nits with 10–30 inappropriate C-terminal acids, which
might be sufficient to support a low level of calpain activ-
ity. However, expression of calpains with these modified
small subunits did not give rise to any detectable calpain
activity when expressed in E. coli, although their function-
ality in mammalian cells has yet to be determined (J.S.
Elce, unpublished work) It has also been suggested that
calpain large subunits alone might provide some activity
in eukaryotic cells, although the Zimmerman et al. knock-
out appears to exclude that possibility, and no calpain
activity was observed in our hands when calpain large
subunits were expressed alone either in E. coli or in mam-
malian cells [36]. The different timing of lethality in the
Capn4 knockouts might also be a consequence of the dif-
ferent genetic backgrounds of the two transgenic lines,
which has been observed to influence the phenotype of
transgenic mice on a number of occasions [37].
One of the enduring questions in calpain research has
been whether the two ubiquitous isoforms, µ- and m-cal-
pain, possess distinct in vivo roles. The two enzymes share
62% sequence identity and are very similar in their struc-
ture and biochemistry. Notably, they cleave essentially the
same set of substrates in vitro, suggesting that they have
the potential to carry out the same functions in vivo. On
the other hand, since they require different amounts of
Ca2+ for in vitro activation, it is possible that the two iso-
forms are differentially regulated inside cells. It is now
clear, from the gene targeting work done in mice, that µ-
and m-calpain have some distinct physiological roles, at
least during embryogenesis. As noted, whereas Capn2 null
murine embryos die prior to implantation, homozygous
disruption of the µ-calpain large subunit gene, Capn1, did
not affect the viability of mice [33]. The principal pheno-
type observed as a result of Capn1 deficiency involved a
disturbance in platelet function, possibly at the level of
the tyrosine phosphorylation of certain proteins involved
in platelet activation. Both µ- and m-calpain activities are
present in most mammalian cells, although the published
data, owing to weaknesses in the available methodology,
do not provide reliable estimates of their relative
amounts. Platelets and erythrocytes contain abundant µ-
calpain activity, while m-calpain activity is barely detecta-
ble. Compensation for µ-calpain deficiency by m-calpain
is therefore less likely in platelets and erythrocytes than in
other cell types. As a result, it is not possible to determine
whether the absence of marked phenotype in Capn1-/- ani-
Nested PCR strategy for genotyping of pre-implantation  embryos Figure 4
Nested PCR strategy for genotyping of pre-implanta-
tion embryos. Due to the scarcity of extractable genetic 
material, a nested PCR strategy was developed in order to 
genotype pre-implantation embryos. Separate reactions were 
used to amplify a 429 bp fragment from the wild-type allele 
and a 389 bp segment from the mutant allele, both spanning 
the 3' end of the short (upstream) arm of the targeting vec-
tor. In both reactions, a 213 bp sequence located within the 
short arm was co-amplified with the 'diagnostic' products as 
an internal control. The same sense primers were used to 
amplify 'diagnostic' sequences in both reactions, whereas the 
antisense primers were allele-specific. The primers, repre-
sented by triangles, are depicted in two (nested) sets for 
each of the three reactions. Exons are represented by open, 
vertical rectangles, the PGK-Neo cassette by an open, hori-
zontal rectangle, while thin vertical lines denote the bounda-
ries of the short arm and the 5' end of the long 
(downstream) arm. A grey, horizontal rectangle delineates 
the segment of the wild-type allele that is replaced by the 
PGK-Neo cassette in the mutant allele.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
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mals is due to a compensatory affect by the remaining m-
calpain activity, or whether the functions of µ-calpain are
simply not essential. In contrast, lethality in Capn2-/-
embryos demonstrates that m-calpain activity is essential
for embryonic development beyond the 8-cell stage. It fol-
lows that at least some functions of µ-calpain and m-cal-
pain are distinct.
The underlying cause of the preimplantation lethality in
Capn2-/-  embryos has not yet been clarified. The two
homozygous null embryos identified at the 8-cell stage
did not present any obvious morphological defects. How-
ever, the fact that only two out of 90 successfully geno-
typed pre-implantation embryos proved to be Capn2-/- is
in itself revealing. Preimplantation lethality resulting
from gene knockouts can typically be attributed to two
general causes. In some cases, defects are incurred in the
embryonic differentiation program which can often be
observed morphologically [38]. Null embryos of this type
often survive beyond the morula stage, and a Mendelian
distribution of embryonic genotypes is usually noted. In
other cases, however, the gene disruption is thought to
compromise fatally the viability of cells in the early
embryo [3,39-43]. In these instances, only a few null
embryos are ever observed and homozygous mutant ES
cells could not be isolated. The Capn2 knockout fits into
the latter category. If it is true that m-calpain is essential
for some aspect of cell viability, the survival of a few
Capn2-/- embryos to the 8-cell stage is most likely due to
the persistence of some maternal m-calpain mRNA and/or
protein through 2–3 cell divisions.
The mechanistic reasons for lethality in the absence of m-
calpain are still unclear. There have been several reports of
m-calpain involvement in cell proliferation in certain cir-
cumstances, including reports of its involvement in chro-
mosome segregation during mitosis [44] as well as during
meiosis [45]. Defects in migration, reported in Capn4-/-
cells [9], could contribute to failed embryonic develop-
ment. The association between calpain and cell viability
has been noted in Capn4-/- MEFs and other cell lines,
although the reported work frequently did not distinguish
between µ- and m-calpain, and did not show that calpain
was strictly essential [5,6]. In both CHO cells and Capn4-/
- MEFs, calpain was shown to influence cell proliferation,
but only at very low cell densities [5]. Calpain has also
been associated with progression through the G1 stage of
the cell cycle [6]. Furthermore, some of the proteins
known to be involved in cell cycle progression, such as
p53, p107, cyclin D1, and p27kip1 are reputed to be cal-
pain substrates [3].
Sperm binding to the oocyte leads to increased cytoplas-
mic calcium which triggers the acrosome reaction [46].
Both  µ- and m-calpain have recently been detected in
rodent sperm [47] and oocytes [45]. m-calpain was impli-
cated in the acrosome reaction [47] which correlated with
a translocation of m-calpain to the cortical membrane in
oocytes where it might participate in the release of cortical
granule contents required to prevent polyspermy [45]. m-
calpain also relocalized to the oocyte meiotic spindle after
fertilization, were it could be involved in chromosome
segregation [45]. Polyspermy or defective chromosome
segregation would both have lethal effects on early embry-
onic development.
It should also be stressed that Capn4-/- ES and MEF cells
from the presumptive hypomorphic allele can be main-
tained in culture despite an apparent lack of calpain activ-
ity, as assessed by casein zymography or by the
appearance of characteristic spectrin breakdown products.
It is conceivable, as discussed earlier, that a trace amount
of calpain activity, beneath levels detectable by these
methods, is retained from this mutant Capn4 allele, and it
Genotyping of pre-implantation embryos Figure 5
Genotyping of pre-implantation embryos. A nested 
PCR strategy was used to genotype embryos prior to implan-
tation as described in Figure 4. Capn2+/- mice were mated and 
the date of fertilization established by the appearance of vagi-
nal plugs. Blastocyst (E3.5) or 8-cell embryos (E2.5) were 
flushed from the oviducts and then digested with proteinase 
K. In separate reactions segments found exclusively in either 
the wild-type or mutant alleles were co-amplified with an 
internal control sequence, located in the short (upstream) 
arm of the targeting vector, which is found in both alleles. 
The final products were 429 bp for the wild-type allele, 389 
bp for the mutant allele, and 213 bp for the internal control. 
(A) A representative example of the genotyping of blastocyst 
stage embryos. Embryos #1, 2, 4, 5, and 6 were Capn2+/- 
whereas embryos #3 and #7 were Capn2+/+, denoted by the 
absence of the 389 bp mutant signal. (B) An example of the 
genotyping of 8-cell embryos is shown. Embryos #1, 2, 3, 5, 
and 6 were Capn2+/- while embryo #4 was Capn2-/-, marked 
by the absence of the 429 bp wild-type signal. (M) denotes 
the molecular weight marker.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
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is sufficient for maintaining the viability of the cells. Fur-
thermore, calpain-independent mechanisms for protect-
ing cell viability might exist in these cell lines that are
absent in early embryonic cells.
The repeated failure to achieve gene conversion of Capn2+/
- to Capn2-/- ES cells by selection of clones in high concen-
trations of G418 suggests that the homozygous mutant
state somehow compromises cell viability or clonal selec-
tion of ES cells. Efforts are under way to express the m-80
k subunit from a Capn2 cDNA rescue transgene prior to
gene conversion in order to preemptively rescue m-cal-
pain activity before the remaining endogenous wild-type
allele is lost. However, difficulty in achieving stable
expression of the rescue transgene has thus far hampered
these attempts.
One curiosity which arose during the genotyping of prog-
eny from heterozygous interbreeding was the highly non-
Mendelian ratio of Capn2+/+ (11.6%) to Capn2+/- (88.4%)
of weanlings. At present, there is no obvious explanation
for this result. Crosses between wild-type and hetero-
zygous mice also produced progeny with a greater than
expected proportion of heterozygous offspring. Interest-
ingly, heterozygous crosses involving the Capn4  trans-
genic line generated by Zimmerman and colleagues
yielded progeny with a similar, if less extreme, skewing in
favor of the heterozygous genotype. Out of a total of 80
genotyped animals, 22.5% were wild-type and 77.5%
were heterozygous, with no homozygous null progeny
observed [32]. These observations suggest a developmen-
tal advantage associated with reduced calpain expression.
Perhaps future studies will reveal a mechanistic basis for
this.
Conclusion
The work presented here has clarified two important ques-
tions regarding the physiological roles of the two ubiqui-
tous calpain isoforms, µ- and m-calpain. Firstly, it was
determined that m-calpain plays an indispensable role in
murine embryogenesis, possibly related to pre-implanta-
tion development. Furthermore, this function cannot be
carried out by µ-calpain despite the apparent in vitro sim-
ilarities of µ- and m-calpain, demonstrating that the two
isoforms clearly have some distinct roles in vivo. The func-
tions of m-calpain during post-implantation embryogen-
esis and in adult mice remain to be elucidated and will
have to be addressed using a conditional gene targeting
strategy.
Methods
Cloning and sequencing of the mouse Capn2 locus
The mouse Capn2 gene encodes the 700 amino acids of
the m-calpain large subunit (m-80 k) and consists of 21
exons extending over 50-kb on chromosome 1. A cDNA
clone encoding a portion of the mouse m-80 k subunit
was purchased (dbEST Id, 807416, Image:606689, Image
Consortium, LLNL). It was found to contain 2.8-kb of
sequence from position 247 of the coding sequence to the
stop codon at position 2,101, including the 3'-UTR to the
polyA signal. A fragment of this cDNA was subcloned and
used to screen a 129Sv mouse genomic library in λ-Dash
II. Overlapping genomic clones were obtained covering
15,354 bp, extending from a BamHI site in intron 3 to a
BamHI site in intron 15. These clones were sequenced
completely on both strands and the data were submitted
to GenBank (accession no. AF497625). The submitted
sequences agreed precisely with the public databases, and
also filled in several small gaps corresponding to short
repetitive sequences which could only be firmly estab-
lished by repeated sequencing in non-standard condi-
tions.
Construction of the Capn2 targeting vector
A targeting construct was designed to replace a 785 bp
BamHI-HindIII fragment, containing exon 7 of the Capn2
gene, with the PGK-Neo cassette (Figure 1). Exon 7
encodes 24 amino acids in the active-site region, includ-
ing Asn286, one of the catalytic triad residues. The short
(upstream) arm of the targeting construct was provided by
a 2.7-kb HindIII-BamHI fragment, containing exons 5 and
6, which was inserted into the pPNT vector upstream of
the PGK-Neo cassette [48]. During cloning, the BamHI site
at the 3' end of the short arm was abolished. The loss of
this BamHI site in the mutant allele, coupled with the
introduction of a new BamHI site at the 3' end of the PGK-
Neo cassette, provided a basis for distinguishing the wild-
type and mutant alleles by Southern blotting. The long
(downstream) arm of homology was provided by a 7-kb
HindIII-KpnI fragment, extending from intron 7 to intron
12, inserted between the PGK-Neo and thymidine kinase
(tk) cassettes.
ES cell culture, transfection and selection of targeted 
clones
Mouse R1 ES cells [49] were maintained on gelatin-coated
plates with feeder layers of mouse embryonic fibroblasts
at 37°C under 5% CO2 in ES cell medium (DMEM [high
glucose] supplemented with 15% fetal bovine serum, 0.1
mM non-essential amino acids, 2 mM glutamine, 1 mM
sodium pyruvate, 0.1 mM 2-mercaptoethanol, 100 U/ml
penicillin, 100 µg/ml streptomycin, 25 µg/ml amphoter-
icin, and 1,000 U/ml of ESGro [Chemicon]). Fetal bovine
serum from HyClone Laboratories Inc (Logan, Utah) was
tested for its ability to support ES cell growth. Gelatin was
from Sigma-Aldrich Canada (Oakville, Ontario). Unless
otherwise specified, all other tissue culture reagents were
from Gibco-BRL.BMC Developmental Biology 2006, 6:3 http://www.biomedcentral.com/1471-213X/6/3
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The targeting construct was linearized by NotI digestion
and electroporated into R1 ES cells. Cells were plated
without feeder layers on gelatin-coated plates and trans-
formed clones were selected in the presence of 200 µg/ml
G418 (Gibco- BRL) and 2 µM ganciclovir (Syntex, Inc.) for
eight days. Drug-resistant clones were picked, expanded
on gelatin-coated plates, and genotyped by Southern blot-
ting and PCR analysis (see below).
Generation of targeted mice
Capn2+/- ES cells were aggregated overnight with 8-cell
embryos recovered from CD1 matings, as previously
described [31]. On the next day, blastocysts were trans-
ferred to pseudopregnant CD1 females. Chimeric animals
were identifiable at birth by black eye pigmentation and
subsequently by patches of agouti coat colour. Chimeric
males were bred with CD1 females to identify those males
capable of germline transmission. These were then bred
with 129SvJ females to establish the mutation in an
inbred genetic background. Mouse protocols were
approved by the Queen's University Animal Care Com-
mittee according to the guidelines of the Canadian Coun-
cil on Animal Care.
Genotyping methods
Several Southern blot and PCR strategies were exploited in
order to determine the genotype of the Capn2  locus.
Southern blotting was carried out using the digoxigenin
(DIG) non-radioactive system (Roche). In most cases,
membranes were blotted with BamHI-digested genomic
DNA and hybridized with a DIG-labeled 823 bp exon 4-
containing BamHI-HindIII fragment located immediately
upstream of the short arm of homology (Figure 1). A 681
bp PstI-XbaI fragment from the PGK-Neo cassette was also
used to probe Southern blots in order to verify a single
integration event in targeted clones.
Genotyping was also carried out by PCR analysis of
genomic DNA. The sequences of all oligonucleotide prim-
ers are listed in Table 1. A single-step PCR strategy was suf-
ficient for genotyping ES cells or biopsies from post-
implantation embryos and weanlings (Figure 1). A 2,748
bp segment of the wild-type allele and a 2,711 bp segment
of the mutant allele were amplified in separate reactions
using a common (intron 4) sense primer, located outside
the short arm of homology, and distinct antisense primers
which hybridized to either wild-type (exon 7) or mutant
(PGK-Neo) sequence (Table I). The thermocycling param-
eters included a five minute initial denaturation step at
95°C, 30 cycles of one minute denaturation at 95°C, one
minute annealing at 56°C, and one minute extension at
72°C, with a ten minute final extension step.
Due to the limited amount of genetic material available in
pre-implantation embryos, a nested PCR strategy was
developed to yield reliable genotyping information (Fig-
ure 4). Whole embryos were first digested in 20 µL of pro-
teinase K buffer (see below). The lysate was then divided
in two, with half (10 µL) being used in the amplification
of the wild-type allele and the remaining 10 µL in the
amplification of the mutant allele.
The first reaction in the nested PCR amplification of the
wild-type allele was carried out in a final reaction volume
of 50 µL, using an intron 6 sense primer and an antisense
primer located in intron 7. Two µL of the first reaction
were used as template in the second PCR amplification
using another intron 6 sense primer and an antisense
primer in exon 7. The nested amplification of the mutant
allele was carried out similarly. The first primer pair con-
sisted of the intron 6 sense primer and an antisense
primer in the PGK-Neo cassette. The nested primer pair
was comprised of the second intron 6 sense primer and an
antisense primer also located within the PGK-Neo
sequence. It should be noted that amplification of both
sequences involved the same sense primers in both steps
of the nested PCR strategy. In addition, the two sets of
reactions included a common internal control designed to
amplify a genomic region within the short arm of the tar-
geting vector that is preserved in both the wild-type and
mutant alleles. The first primer pair of the control PCR
was made up of an intron 4 sense primer and an intron 5
antisense primer. The second primer pair comprised an
exon 5 sense primer and a nested intron 5 antisense
primer. The final products were 213 bp for the control
PCR, 429 bp for the wild-type PCR, and 389 bp for the
mutant PCR. All reactions were carried out using identical
PCR conditions entailing an initial five minute denatura-
tion at 95°C, 35 cycles of one minute denaturation at
95°C, one minute annealing at 56°C, and one minute
extension at 72°C, with a final extension step of ten min-
utes.
Isolation of pre-implantation embryos
Time of fertilization was determined by observation of
copulation plugs, and noon of that day was defined as
E0.5. Pre-implantation embryos were obtained by dissect-
ing the uteri out of pregnant females at E2.5 or E3.5 and
flushing the oviducts with ES cell medium. Isolated
embryos were then digested for five hours at 55°C in 20
µL of lysis buffer (50 mM Tris-HCl, 0.5% Triton X-100,
200 µL/mL proteinase K, pH 8.0), followed by ten min-
utes at 95°C to inactivate the proteinase K. Lysates were
then used for PCR genotyping.
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